TRPM2 and cerebral infarction: Studies have also demonstrated that genetic deletion of TRPM2 can alleviate hypoxic-ischemic brain injury in neonatal mice, characterized by reduced post-I/R cerebral infarct size and improved sensorimotor deficits (142).